Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's DiseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized how the fecal microbiota is altered in Crohn's disease (CD), a form of inflammatory bowel disease. The aim was to identify which bacterial species define the dysbiosis seen in CD. Researchers sequenced the V3-V4 regions of the 16S rRNA gene using the Illumina MiSeq system. They then confirmed key findings in a larger set of patients and controls using quantitative PCR, and compared bacteria against C-reactive protein status as a marker of inflammation.
Who was studied?
The discovery stage compared fecal samples from 10 patients with inactive CD and 10 healthy individuals. The work was based on human stool samples. The validation stage used quantitative PCR in an additional 68 CD patients and 46 healthy controls. Sequencing yielded an average of 62,201 reads per CD sample, significantly fewer than the average 73,716 reads per control sample, reflecting reduced microbial content in the CD group.
What were the most important findings?
Butyrate-producing bacteria were markedly depleted in Crohn's disease. At the species level, Blautia faecis, Roseburia inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis and Faecalibacterium prausnitzii were significantly reduced versus healthy controls (p below 0.05). At the genus level, Bacteroides, Eubacterium, Faecalibacterium and Ruminococcus decreased, while Actinomyces and Bifidobacterium increased in CD. Roseburia inulinivorans and Ruminococcus torques were significantly lower in C-reactive-protein-positive CD patients than in CRP-negative patients (p below 0.05).
What are the greatest implications of this study?
The findings suggest Crohn's disease dysbiosis is defined by loss of multiple butyrate-producing species. Butyrate feeds colonic cells and has anti-inflammatory effects, so its depletion may contribute to disease. Because certain butyrate producers tracked with C-reactive protein, they may relate to inflammatory activity and could serve as candidate markers. Causation cannot be established here. The discovery cohort was small and cross-sectional, so it shows association rather than proof that depletion drives Crohn's disease.